SKYE BIOSCIENCE INC. - COMMON STOCK

3.1000

08-January-25 16:45:00

15 minutes delayed

Stocks

+0.0300

+0.98%

Today's range

2.9600 - 3.2500

ISIN

N/A

Source

NASDAQ

Skye Concentrates Strategy and Clinical Development Focus on Nimacimab Metabolic Program

10 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
Skye Bioscience to Present at Jefferies Global Healthcare Conference

03 Jun 2024 07:00:00 By Nasdaq GlobeNewswire
Skye Bioscience Highlights Novel Synthetic Cannabinoid-based Library Capable of Modulating the Endocannabinoid System to Treat Ocular Diseases at ARVO 2024 Annual Meeting

10 May 2024 07:00:00 By Nasdaq GlobeNewswire
Skye Bioscience to Present Two Posters at Association for Research in Vision and Ophthalmology (ARVO) 2024 Annual Meeting

30 Apr 2024 07:00:00 By Nasdaq GlobeNewswire
Skye Bioscience to Present at Upcoming Investment Conferences

23 Apr 2024 07:00:00 By Nasdaq GlobeNewswire

<<
<
1
2
>

I Agree NetDania's website uses cookies. By continuing browsing our website, you agree to our Cookie Policy, Privacy Policy and Terms and Conditons.